Market Movers

Meitu’s Stock Price Skyrockets to 4.20 HKD, Notching a Robust 15.38% Gain: A Stellar Performance Unveiled

By January 30, 2025 No Comments

Meitu (1357)

4.20 HKD +0.56 (+15.38%) Volume: 90.56M

Meitu’s stock price soared to 4.20 HKD, logging a remarkable 15.38% increase this trading session, with a high trading volume of 90.56M. The stock continues its bullish trend with a year-to-date percentage change of +41.41%, solidifying its strong market performance.


Latest developments on Meitu

Today, Meitu Inc‘s stock price surged as the Hang Seng Index closed at 20,225 points, up 27 points, and the Hang Seng Tech Index closed at 4,723 points, up 36 points. Amidst this positive market momentum, Meitu Inc, along with Xiaomi and Kingsoft, reached new highs. Additionally, Ali Health saw an increase of over 4%, reflecting the overall bullish sentiment in the market towards tech stocks.


A look at Meitu Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth5
Resilience3
Momentum4
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Meitu Inc, a company that offers mobile application software, has received positive scores in Growth and Dividend from Smartkarma Smart Scores, indicating a strong long-term outlook for the company in terms of expansion and potential returns for investors. With a high score in Momentum as well, Meitu Inc shows promising signs of continued market performance and innovation in the mobile software industry.

Although Meitu Inc has received slightly lower scores in Value and Resilience, the overall outlook remains optimistic with a solid foundation in growth and dividends. The company’s involvement in image editing, live broadcasting, and social software, as well as mobile designing and retailing, positions it well for future success and continued market competitiveness.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars